NO20033163L - Ny anvendelse av iloperidon - Google Patents

Ny anvendelse av iloperidon

Info

Publication number
NO20033163L
NO20033163L NO20033163A NO20033163A NO20033163L NO 20033163 L NO20033163 L NO 20033163L NO 20033163 A NO20033163 A NO 20033163A NO 20033163 A NO20033163 A NO 20033163A NO 20033163 L NO20033163 L NO 20033163L
Authority
NO
Norway
Prior art keywords
iloperidone
new use
new
Prior art date
Application number
NO20033163A
Other languages
English (en)
Other versions
NO20033163D0 (no
Inventor
Hans O Kalkman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20033163D0 publication Critical patent/NO20033163D0/no
Publication of NO20033163L publication Critical patent/NO20033163L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20033163A 2001-02-05 2003-07-10 Ny anvendelse av iloperidon NO20033163L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102841.4A GB0102841D0 (en) 2001-02-05 2001-02-05 Organic compounds
PCT/EP2002/001130 WO2002064141A1 (en) 2001-02-05 2002-02-04 New use of iloperidone

Publications (2)

Publication Number Publication Date
NO20033163D0 NO20033163D0 (no) 2003-07-10
NO20033163L true NO20033163L (no) 2003-07-10

Family

ID=9908143

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033163A NO20033163L (no) 2001-02-05 2003-07-10 Ny anvendelse av iloperidon

Country Status (21)

Country Link
US (4) US20040072869A1 (no)
EP (1) EP1370262A1 (no)
JP (1) JP4278981B2 (no)
KR (1) KR100851256B1 (no)
CN (1) CN1226035C (no)
AU (1) AU2002231766B2 (no)
BR (1) BR0206918A (no)
CA (1) CA2434900C (no)
CZ (1) CZ301357B6 (no)
GB (1) GB0102841D0 (no)
HU (1) HUP0303136A3 (no)
IL (3) IL156819A0 (no)
MX (1) MXPA03006970A (no)
NO (1) NO20033163L (no)
NZ (1) NZ527111A (no)
PL (1) PL362550A1 (no)
RU (1) RU2301065C2 (no)
SK (1) SK9812003A3 (no)
TW (1) TWI322011B (no)
WO (1) WO2002064141A1 (no)
ZA (1) ZA200305331B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005292246B2 (en) 2004-09-30 2011-07-07 Vanda Pharmaceuticals, Inc Methods for the administration of iloperidone
US20100063093A1 (en) 2007-03-28 2010-03-11 Curt Wolfgang Methods for the administration of iloperidone
RU2008150624A (ru) * 2006-05-22 2010-06-27 Ванда Фармасьютиклз, Инк. (Us) Лечение депрессивных расстройств
CN101822673B (zh) * 2009-03-04 2013-09-18 北京德众万全药物技术开发有限公司 一种含有伊潘立酮的固体药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126512T1 (de) * 1989-05-19 1995-09-15 Hoechst Roussel Pharma N-(aryloxyalkyl)heteroarylpiperidine und - heteroarylpiperazine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
FR2654104B1 (fr) * 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CA2300148C (en) * 1997-08-11 2009-06-23 University Of South Florida Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
KR20010072878A (ko) * 1998-10-16 2001-07-31 디르크 반테 인식을 개선하기 위한 아세틸콜린에스테라제 억제제와배합된 비정형 항정신병제
EP1242058A1 (en) * 1999-04-07 2002-09-25 Pfizer Products Inc. Use of cyp2d6 inhibitors in combination therapies

Also Published As

Publication number Publication date
US20090131477A1 (en) 2009-05-21
NZ527111A (en) 2005-05-27
CZ20032114A3 (cs) 2004-01-14
EP1370262A1 (en) 2003-12-17
JP2004517959A (ja) 2004-06-17
IL156819A0 (en) 2004-02-08
NO20033163D0 (no) 2003-07-10
IL156819A (en) 2008-03-20
RU2003126175A (ru) 2005-03-10
CN1226035C (zh) 2005-11-09
SK9812003A3 (en) 2004-04-06
HUP0303136A2 (hu) 2003-12-29
AU2002231766B2 (en) 2005-12-22
US20040072869A1 (en) 2004-04-15
WO2002064141A1 (en) 2002-08-22
TWI322011B (en) 2010-03-21
CA2434900C (en) 2010-10-05
ZA200305331B (en) 2004-05-12
HUP0303136A3 (en) 2006-05-29
CA2434900A1 (en) 2002-08-22
CZ301357B6 (cs) 2010-01-27
CN1531432A (zh) 2004-09-22
US20060205786A1 (en) 2006-09-14
MXPA03006970A (es) 2003-11-18
PL362550A1 (en) 2004-11-02
IL188485A0 (en) 2008-03-20
GB0102841D0 (en) 2001-03-21
US20080103177A1 (en) 2008-05-01
BR0206918A (pt) 2004-02-03
RU2301065C2 (ru) 2007-06-20
KR20030070599A (ko) 2003-08-30
KR100851256B1 (ko) 2008-08-08
JP4278981B2 (ja) 2009-06-17

Similar Documents

Publication Publication Date Title
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20023616D0 (no) Ny anvendelse
NO20014495L (no) Ny anordning for oksygenering av sjövann
ID30187A (id) Dongkrak jenis pantagraf
NO20035121D0 (no) Ny anvendelse
NO20044916L (no) Preparater av sulfinylacetamid
DE60126814D1 (de) Inhalation von stickoxid
NO20041968L (no) Anvendelse av cystationin
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
IL188485A0 (en) New use of iloperidone
NO20033919L (no) Ny anvendelse
FI20012295A (fi) Hyvyysluku
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20025765L (no) Kombinasjonssett for behandling av malaria
ATE354561T1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen
NO20023243D0 (no) Ny terapeutisk anvendelse av enoxaparin
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
AT4005U3 (de) Hornhautraspel
SE0103291D0 (sv) New use
SE0103540D0 (sv) New Use
SE0104065D0 (sv) New use
SE0103768D0 (sv) New use
SE0103767D0 (sv) New use
SE0100062D0 (sv) New use
SE0104092D0 (sv) New use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application